Wegovy
E1337167
UNEXPLORED
Wegovy is a prescription weight-loss medication (semaglutide) developed by Novo Nordisk, used to help adults with obesity or overweight manage their weight alongside diet and exercise.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Wegovy canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T18644848 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Wegovy Context triple: [Novo Nordisk, majorProduct, Wegovy]
-
A.
Saxenda
Saxenda is a prescription weight-loss medication (liraglutide) developed by Novo Nordisk that helps manage obesity by mimicking the GLP-1 hormone to reduce appetite.
-
B.
Ozempic
Ozempic is a prescription semaglutide medication primarily used to improve blood sugar control in adults with type 2 diabetes and widely known for its weight-loss effects.
-
C.
Mounjaro
Mounjaro is a prescription medication (tirzepatide) used primarily to improve blood sugar control in adults with type 2 diabetes and increasingly known for its weight-loss effects.
-
D.
Trulicity
Trulicity is a prescription GLP-1 receptor agonist medication used to improve blood sugar control in adults with type 2 diabetes.
-
E.
Rybelsus
Rybelsus is an oral semaglutide medication used to improve blood sugar control in adults with type 2 diabetes.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Wegovy Target entity description: Wegovy is a prescription weight-loss medication (semaglutide) developed by Novo Nordisk, used to help adults with obesity or overweight manage their weight alongside diet and exercise.
-
A.
Saxenda
Saxenda is a prescription weight-loss medication (liraglutide) developed by Novo Nordisk that helps manage obesity by mimicking the GLP-1 hormone to reduce appetite.
-
B.
Ozempic
Ozempic is a prescription semaglutide medication primarily used to improve blood sugar control in adults with type 2 diabetes and widely known for its weight-loss effects.
-
C.
Mounjaro
Mounjaro is a prescription medication (tirzepatide) used primarily to improve blood sugar control in adults with type 2 diabetes and increasingly known for its weight-loss effects.
-
D.
Trulicity
Trulicity is a prescription GLP-1 receptor agonist medication used to improve blood sugar control in adults with type 2 diabetes.
-
E.
Rybelsus
Rybelsus is an oral semaglutide medication used to improve blood sugar control in adults with type 2 diabetes.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.